Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

DR info

Clinical trials : 15 / Drugs : 6 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathways : 3

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

Nitisinone
   Cycle Pharmaceuticals Ltd.
      2015   Phase 1   NCT02750332   South Africa
   Sutphin Drugs
      2019   -   NCT04113772   India
   Swedish Orphan Biovitrum
      2025   -   NCT06227429   China
      2014   Phase 3   NCT02323529   Belgium;Denmark;France;Germany;Sweden
      2013   -   NCT02320084   Austria;Belgium;Croatia;Czech Republic;Czechia;Denmark;Finland;France;Germany;Greece;Hungary;Ireland;Italy;Kosovo;Lithuania;Macedonia, The Former Yugoslav Republic of;Netherlands;Norway;Poland;Portugal;Romania;Slovakia;Spain;Sweden;Switzerland;United Kingdom
      2012   Phase 1   NCT01734889   France;Germany;United Kingdom
   Swedish Orphan Biovitrum AB
      2012   -   EUCTR2012-002286-36-GB   Germany;United Kingdom
      2012   -   EUCTR2012-002286-36-DE   Germany;United Kingdom
   Swedish Orphan Biovitrum AB (Publ)
      2014   -   EUCTR2013-004132-29-SE   Belgium;Denmark;Sweden
      2014   -   EUCTR2013-004132-29-DK   Belgium;Denmark;Sweden
      2014   Phase 4   EUCTR2013-004132-29-BE   Belgium;Denmark;Sweden
Nitisinone 10 MG tablet high compritol
   Cycle Pharmaceuticals Ltd.
      2015   Phase 1   NCT02750709   South Africa
Nitisinone baked tablet
   Cycle Pharmaceuticals Ltd.
      2016   Phase 1   NCT02750345   South Africa
Ntbc
   National Center for Research Resources (NCRR)
      1994   Phase 2   NCT00004333   -
   University of Washington
      1998   -   NCT00004443   Canada;United States
Orfadin
   Cycle Pharmaceuticals Ltd.
      2016   Phase 1   NCT02750345   South Africa
      2015   Phase 1   NCT02750709   South Africa
   Sutphin Drugs
      2019   -   NCT04113772   India
   Swedish Orphan Biovitrum AB (Publ)
      2014   -   EUCTR2013-004132-29-SE   Belgium;Denmark;Sweden
      2014   -   EUCTR2013-004132-29-DK   Belgium;Denmark;Sweden
      2014   Phase 4   EUCTR2013-004132-29-BE   Belgium;Denmark;Sweden
Orfadin oral suspension 4MG/ML
   Swedish Orphan Biovitrum AB
      2012   -   EUCTR2012-002286-36-GB   Germany;United Kingdom
      2012   -   EUCTR2012-002286-36-DE   Germany;United Kingdom